GSK’s net earnings drop by 2.5% owing to a rise in finance cost

Sep-19

Sep-18

% Change

Sales

                     25,824,915

                     25,274,071

2.18%

Cost of Sales

                  (20,259,214)

                  (18,908,179)

7.15%

Gross Profit

                       5,565,701

                       6,365,892

-12.57%

Selling, marketing and distribution expenses

                     (2,432,582)

                     (2,588,864)

-6.04%

Administrative expenses

                        (824,608)

                        (776,093)

6.25%

Other operating expenses

                        (244,845)

                        (298,761)

-18.05%

Other income

                       1,072,894

                           590,607

81.66%

Profit from operations

                       3,136,560

                       3,292,781

-4.74%

Finance cost

                        (275,839)

                           (81,301)

239.28%

Profit before taxation

                       2,860,721

                       3,211,480

-10.92%

Taxation

                     (1,062,372)

                     (1,366,134)

-22.24%

Profit after taxation from continuing operations

                       1,798,349

                       1,845,346

-2.55%

(Loss)/Profit after taxation from discontinued operations

                                      -  

                                      -  

Total profit after taxation

                       1,798,349

                       1,845,346

-2.55%

Earnings per share (Rupees)

                                  5.65

                                  5.87

-3.75%